中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
MeSH:(COVID-19 Vaccines/adverse effects*)

1.Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials.

Hong-Xing PAN ; Jian-Kai LIU ; Bao-Ying HUANG ; Gui-Fan LI ; Xian-Yun CHANG ; Ya-Fei LIU ; Wen-Ling WANG ; Kai CHU ; Jia-Lei HU ; Jing-Xin LI ; Dan-Dan ZHU ; Jing-Liang WU ; Xiao-Yu XU ; Li ZHANG ; Meng WANG ; Wen-Jie TAN ; Wei-Jin HUANG ; Feng-Cai ZHU

Chinese Medical Journal 2021;134(11):1289-1298

3.A review of the safety and efficacy of current COVID-19 vaccines.

Zehong HUANG ; Yingying SU ; Tianying ZHANG ; Ningshao XIA

Frontiers of Medicine 2022;16(1):39-55

4.Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults.

Yuntao ZHANG ; Yunkai YANG ; Niu QIAO ; Xuewei WANG ; Ling DING ; Xiujuan ZHU ; Yu LIANG ; Zibo HAN ; Feng LIU ; Xinxin ZHANG ; Xiaoming YANG

Frontiers of Medicine 2022;16(1):93-101

5.Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting.

Jonathan YAP ; Mun Yee THAM ; Jalene POH ; Dorothy TOH ; Cheng Leng CHAN ; Toon Wei LIM ; Shir Lynn LIM ; Yew Woon CHIA ; Yean Teng LIM ; Jonathan CHOO ; Zee Pin DING ; Ling Li FOO ; Simin KUO ; Yee How LAU ; Annie LEE ; Khung Keong YEO

Annals of the Academy of Medicine, Singapore 2022;51(2):96-100

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO